Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023 Oct;31(5):963-977.
doi: 10.1037/pha0000632. Epub 2023 Jan 12.

Correlations of kratom (Mitragyna speciosa Korth.) use behavior and psychiatric conditions from a cross-sectional survey

Oliver Grundmann  1 , Charles A Veltri  2 , Sara Morcos  2 , Kirsten E Smith  3 , Darshan Singh  4 , Ornella Corazza  5 , Eduardo Cinosi  5 , Giovanni Martinotti  5 , Zach Walsh  6 , Marc T Swogger  7
Affiliations
Observational Study

Correlations of kratom (Mitragyna speciosa Korth.) use behavior and psychiatric conditions from a cross-sectional survey

Oliver Grundmann et al. Exp Clin Psychopharmacol. 2023 Oct.

Abstract

Kratom (Mitragyna speciosa Korth.) use has increased substantially over the past decade outside of its indigenous regions, especially for the self-treatment of psychiatric conditions. An anonymous, cross-sectional, online survey was completed by 4,945 people who use kratom (PWUK) between July 2019 and July 2020. A total of 2,296 respondents completed an extended survey that included clinical scales for measuring attention deficit hyperactivity disorder (ADHD), posttraumatic stress disorder (PTSD), depressive and anxiety disorders. PWUK and met criteria for ADHD, PTSD, depressive or anxiety disorders were primarily middle-aged (31-50 years), employed, college-level educated, and reported greater concurrent or prior use of kratom with cannabis, cannabidiol, and benzodiazepines. For all psychiatric conditions, PWUK reported decreased depressive and anxious moods than before kratom use. Based on this self-report study, observational and other clinical studies are warranted for kratom. (PsycInfo Database Record (c) 2023 APA, all rights reserved).

PubMed Disclaimer

Conflict of interest statement

Financial interests

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Conflict of interest

The Authors declare that there is no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Agapoff JR, & Kilaru U (2019). Outpatient buprenorphine induction and maintenance treatment for kratom dependence: A case study. Journal of Substance Use, 24(6), 575–577. 10.1080/14659891.2019.1638459 - DOI
    1. Babu KM, McCurdy CR, & Boyer EW (2008). Opioid receptors and legal highs: Salvia divinorum and Kratom. Clin Toxicol (Phila), 46(2), 146–152. 10.1080/15563650701241795 - DOI - PubMed
    1. Bath R, Bucholz T, Buros AF, Singh D, Smith KE, Veltri CA, & Grundmann O (2020). Self-reported health diagnoses and demographic correlates with kratom use: Results from an online survey. Journal of Addiction Medicine, 14(3). 10.1097/ADM.0000000000000570 - DOI - PMC - PubMed
    1. Bruton AM, Senders A, Tost G, Ast H, Robinette LM, Leung B, Hatsu IE, Arnold LE, & Johnstone JM (2022). Pain sensitivity and perceptual sensitivity are associated with severity of emotional dysregulation in children with ADHD: a cross-sectional analysis using the Temperament in Middle Childhood Questionnaire. Disability and Rehabilitation, 1–9. - PMC - PubMed
    1. Buckhalter S, Soubeyrand E, Ferrone SAE, Rasmussen DJ, Manduca JD, Al-Abdul-Wahid MS, Frie JA, Khokhar JY, Akhtar TA, & Perreault ML (2021). The Antidepressant-Like and Analgesic Effects of Kratom Alkaloids are accompanied by Changes in Low Frequency Oscillations but not ΔFosB Accumulation. Frontiers in Pharmacology, 12. 10.3389/FPHAR.2021.696461 - DOI - PMC - PubMed

Publication types